GDC-0068

GDC-0068

CAT N°: 18412
Price:

From 85.00 72.25

GDC-0068 is a selective, ATP-competitive, pan-Akt inhibitor that targets Akt1, 2, and 3 with IC50 values of 5, 18, and 8 nM, respectively in cell-free assays.{30936} It is 620-fold selective for Akt over protein kinase A and has been shown to block Akt signaling selectively in cultured tumor cell lines characterized by activated Akt, halting cell cycle progression and reducing cell viability.{30936} In multiple tumor xenograft models, oral administration of GDC-0068 at 100 mg/kg/day can lead to delayed tumor growth and regression.{30936}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • (2S)-?(4-?chlorophenyl)?-?1-?[4-?[(5R,?7R)?-?6,?7-?dihydro-?7-?hydroxy-?5-?methyl-?5H-?cyclopentapyrimidin-?4-?yl]?-?1-?piperazinyl]?-?3-?[(1-?methylethyl)?amino]?-1-?propanone
  • Correlated keywords
    • 1417449-25-2 1396257-94-5 1489263-16-2 GDC0068 RG7440 pan-Akt Akt1/2/3 panAkt Akt1 Akt2 Akt3 Akt-1 Akt-2 Akt-3 GDC68 GDC-68
  • Product Overview:
    GDC-0068 is a selective, ATP-competitive, pan-Akt inhibitor that targets Akt1, 2, and 3 with IC50 values of 5, 18, and 8 nM, respectively in cell-free assays.{30936} It is 620-fold selective for Akt over protein kinase A and has been shown to block Akt signaling selectively in cultured tumor cell lines characterized by activated Akt, halting cell cycle progression and reducing cell viability.{30936} In multiple tumor xenograft models, oral administration of GDC-0068 at 100 mg/kg/day can lead to delayed tumor growth and regression.{30936}

We also advise you